Home | Medical-Newswire.Com:
(Medical-NewsWire.com, September 20, 2012 ) New York, NY -- Advanced Medical Isotope Corporation (ADMD) is already a US-based manufacturer and distributor of medical isotopes and is also developing key technologies that may offer a superior alternative to the current standard of care for battling cancer with nuclear medicine.
In a Thursday report, VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, identifies key point for optimism regarding the company and examines its speculative potential as an investment. Full report available at: http://vfcsstockhouse.com/blog/article/-advanced-medical-isotope-corporation-expanded-distribution-and-radiogel-technology-hold-the-keys-to-the-future
Advanced Medical Isotope Corporation (ADMD) has - through key partnerships, expanding distribution channels and the acquisition of a license to a novel cancer-fighting technology - well positioned itself to become a growth player in the field of nuclear medicine, specifically in the field of the production and distribution of medical isotopes. Medical isotopes are used in molecular imaging, therapy, and nuclear medicine to diagnose, manage and treat diseases and are deemed a hot item whenever discussed because of the geopolitical implications of non-nuclear nations attempt to enrich uranium for - ahem - solely medical purposes.
Advanced Medical is one of only a few companies in the United States manufacturing and distributing such isotopes and it's likely that business could quickly hit a growth spurt - not only through the company's own indigenous expansion and distribution efforts, but also because of the growing desire of the medical community in the US to use 'home grown' nuclear materials, not to mention increasing regulation that may force the community to do so anyway.
AMIC already offers a broad variety of isotopes and, as outlined in a recent quarterly report, is looking to expand its 'pipeline' of product offerings for its distribution network of customers that include - but is not limited to - national laboratories, hospitals, research facilities and universities.
Many of the company's isotopes are put to use through molecular imaging, or Positron Emission Tomography (PET), which enables Doctors and medical professionals to identify cancerous condictions well before detection means that search for tumor mass. Some of the radiopharmaceutical products based on the medical isotopes are also used in the early detection of certain cardiovascular indications and, as mentioned above, the demand for such products is growing, not shrinking. According to numbers identified in a recent company presentation and credited to the World Nuclear Association, the use of medical isotopes is growing at an annual rate of 10%.
That places AMIC right in the middle of a potential growth boom.
While production and distribution may encompass the company's core business model, AMIC is moving heavily into the field of treatment, too. The process of placing radioactive "seeds" in or near a cancerous tumor is known as brachytherapy, and AMIC is developing a pipeline based on such technology to augment the already-growing core business plan.
In April, the company acquired a license and numerous relating patents to an injectible radiogel technology that could have a significant impact on the next generation of fighting cancer. Using the radiogel technology doctors could deliver Yttrium-90 "microspheres" directly into cancerous tissue. Because the injectible polymer turns solid and holds the microspheres in place, there is little to no threat of any radiation escaping and damaging surrounding tissue. As described by Dr. Alan Walter, Chair of the AMIC Scientific Committee, in a presentation available on the company's home page, such a technology could be termed as using "smart bullets" to target cancerous cells.
Yttrium-90, in the form of Polymer seeds, is an already-established medical isotope with numerous applications in existing cancer treatment and has demonstrated effectiveness in combating head, neck, liver and prostate cancers, according to an above-linked company presentation. The radiogel application of Yttrium-90 could potentially 'storm the scene' in treating numerous cancer types with the intent of targeting those tumors in the hard-to-get to areas of the body that eliminates surgery as an option.
Both the Polymer seeds and the acquired the radiogel technology significantly boost the diversity of AMIC, offering a targeted path to enter the realm of caner treatment to augment the production, sales and distribution channels of its isotopes.
It's possible, based on previous expectations, that the Brachytherapy pipeline could hit market within a couple of years. At that point AMIC could either move forward with commercialization on its own or out-license the technology to someone else and use that revenue stream of royalties to fund the expansion of the core business.
Shares were up by eight percent on Wednesday, although volume was very light. That said, volume has been picking up significantly over the past few months and has tripled already once this year. Volume has also stormed in after the company's more relevant press releases, indicating that there are investors on the sidelines who either wait to play a quick trade or may be taking a 'wait and see' approach to playing this still-speculative stock.
Should the potential of the AMIC distribution network continue to expand and meet the growing demand for nuclear medicine - and should the polymer seeds and radiogel technology also hit market with momentum - then it's likely that the current ADMD share price could start to move. Currently, shares consistently trade for a few pennies above the twenty cents mark, give or take.
Based on the potential of the developing technology, already-available products and future product offerings, the current ADMD trading levels could serve as an opportune accumulation period to those looking at the risk/reward profile for the future. The current market cap of still under twenty million indicates that many investors are still unconvinced, but when searching for potential payoff picks on the bulletin board stocks, it pays off to be in while the stock is still moving along relatively unnoticed, as the best percentage gains to be had in any run start with being in place before the run starts.
That said, the stock market is risky business and there are no sure things, that's why it's up to each investor to conduct his or her own DD and invest accordingly.
Still a developing story worth monitoring.
Disclosure: No position.
Follow ADMD developments and other small cap stocks at VFCsStockHouse.com
Contact VFC's Stock House: email@example.com
Follow VFC's Stock House on Twitter: https://twitter.com/#!/VFCsStockHouse
'Like' VFC's Stock House on Facebook: http://www.facebook.com/pages/VFCs-Stock-House/143724412345213
VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks, biopharma stocks, and pharmaceutical and healthcare stocks. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights and opinions into broader-market news. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFC’s Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and make informed and well thought-out investment decisions. For full disclaimer visit: http://vfcsstockhouse.com
VFC's Stock House
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on
top health stories.
Judge enforces Ebola isolation of defiant Maine nurse
31 Oct 2014 at 10:10am
By Joel Page FORT KENT Maine (Reuters) - A judge on Friday ordered an American nurse who treated Ebola patients in Sierra Leone for the disease to obey a state-imposed quarantine after she defied Maine officials and went for a bike ride. The temporary order from Charles LaVerdiere, chief judge of the Maine District Court, turned up the heat in the confrontation over the quarantine between the New England state's officials and nurse Kaci Hickox. ...
Judge imposes conditions on Maine nurse, rejects stricter measures: lawyer
31 Oct 2014 at 10:08am
NEW YORK (Reuters) - A Maine judge imposed certain conditions on an American nurse who treated Ebola patients in Sierra Leone but rejected a bid from state officials for more restrictive measures, her lawyer told Reuters. Charles LaVerdiere, chief judge of Maine District Court, on Thursday had earlier instructed Kaci Hickox to avoid "public places" like shopping centers and to maintain a three-foot distance from others at the state's request, hours after she defied officials and went for a bike ride. ...
Judge rejects Ebola quarantine for nurse
31 Oct 2014 at 9:55am
FORT KENT, Maine (AP) ? A Maine judge on Friday rejected a bid by state health officials to restrict the movement of nurse Kaci Hickox, who defied a state quarantine for medical workers who have treated Ebola patients.
Mali Ebola victim had contact with 141 people, 57 still sought
31 Oct 2014 at 9:48am
By Tom Miles GENEVA (Reuters) - A 2-year-old girl who brought Ebola to Mali may have had contact with as many as 141 people, 57 of whom have yet to be traced, according to health experts concerned the disease could spread in Mali and beyond. Two people known to have had contact with the girl were suspected of having the disease, according to a slide presentation by the World Health Organization and the U.S. Centers for Disease Control seen by Reuters on Friday. One of the two had not been tested and the other had been tested but with no result yet known. ...
U.S. envoy to U.N. defends Ebola guidelines; praises airlines
31 Oct 2014 at 9:42am
By Louis Charbonneau and Bill Berkrot NEW YORK (Reuters) - U.S. Ambassador to the United Nations Samantha Power on Friday defended federal guidelines for monitoring health workers returning from three Ebola-stricken West African countries and praised the airlines still flying there. Amid controversy in the United States over some states ordering 21-day quarantines for nurses and doctors returning home after treating Ebola patients, Power said current federal rules balanced "the need to respond to the fears that this has generated" with the known science on the disease. ...
Flu or Ebola? US hospitals prepare for a confusing season
31 Oct 2014 at 9:40am
After weeks of Ebola panic, false alarms and quibbles over quarantine in the United States, health authorities are bracing for a new battle: flu season. The end of October marks the start of influenza season, bringing with it the predictable sniffles, sneezes, fever and aches that can extend well into the spring months. First is the Ebola epidemic in West Africa that spilled into the United States when a Liberian man traveled to Texas in September and infected two nurses who helped care for him. The prospect of facing all three illnesses in a single season has led the CDC to start a public education campaign to help people understand the risks, and to remind people to get their annual flu vaccine.
Africans worst responders in Ebola crisis
31 Oct 2014 at 8:54am
JOHANNESBURG (AP) ? The head of Africa's continental body did not get to an Ebola-hit country until last week ? months after alarm bells first rang and nearly 5,000 deaths later.
On Denton's Upcoming Referendum for a Fracking Ban
31 Oct 2014 at 8:50am
By: Najmedin Meshkati, Nima Jabbari, Jamie Heinecke, and Cyrus Ashayeri As we all know, on November 4 there will be a referendum on a fracking ban in Denton, TX. Regardless of the outcome, the impact of this unprecedented grassroots movement will transcend well beyond Denton's city limits and affect the future of the entire oil and gas fracking...
Staying Lean This Halloween
31 Oct 2014 at 8:47am
It's that time of year when tricks and treats seem to find their way into your pantry, much to the dismay of your weight loss and health goals. A bit of nervousness and fear is probably setting in for you've been here before, and although you often start this season off with the best intentions, "THIS year it's going to be different!" or "THIS...
Sleep apnea tied to memory problems
31 Oct 2014 at 8:45am
By Andrew M. Seaman (Reuters Health) - The ability to remember locations and directions may suffer when deep sleep is disrupted by breathing difficulties, a new study suggests. People with sleep apnea tended to score worse on spatial memory tests after sleeping without their breathing aid, compared to mornings after they?d used their breathing aids at night, researchers found. ?There had been some evidence in animal models that REM sleep or dreaming sleep is important for spatial memory, but no one had shown or proven that in people,? said Dr. ...
Watch: How to Properly Put on a Hazmat Suit
31 Oct 2014 at 8:26am
Doctors at the NIH in Maryland demonstrate the use of protective equipment used for treating Ebola patients.
5 Tips to 'Fall Back' From Daylight Saving Time
31 Oct 2014 at 8:26am
What's better than sleeping in on a Sunday? How about dodging the days-long consequences of rolling the clocks back this weekend?
AbbVie says strong results lessen need for big deal
31 Oct 2014 at 8:23am
By Ransdell Pierson (Reuters) - AbbVie, which this month abandoned its planned $55 billion purchase of Dublin drugmaker Shire, reported impressive quarterly earnings on demand for its Humira arthritis drug and said it could deliver strong long-term growth without rushing into another big merger attempt. "The underlying growth prospects of AbbVie don't require us to do a deal of that size," AbbVie Chief Executive Richard Gonzalez said in conference call, but added the company was keen on smaller acquisitions, particularly of treatments involving rare diseases, cancer and hepatology. ...
Watch: Hannah Storm's Campaign for Children
31 Oct 2014 at 8:22am
The sports journalist is giving back beauty.
Conflicts at home affect teens at school and vice versa
31 Oct 2014 at 8:09am
By Shereen Lehman NEW YORK (Reuters Health) - - Conflicts in a teen's life can spill over at school and at home for days afterward, a new study suggests. Finding out why the spillover occurs, and which teens are most vulnerable to it, could help target ways to interrupt this damaging negative feedback loop, the study team writes in the journal Child Development. ?We know that family conflict is a risk factor for poor school performance, but less is known about how these processes are associated on a daily basis,? lead author Adela Timmons told Reuters Health in an email. ...